[1] Pavia AT. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis, 2011,52 Suppl 4:S284-289. [2] Bialasiewicz S,Whiley DM,Lambert SB,et al. Detection of BK, JC, WU, or KI polyomaviruses in faecal, urine, blood, cerebrospinal fluid and respiratory samples. J Clin Virol,2009,45(3):249-254. [3] Sloots TP, Whiley DM, Lambert SB, et al. Emerging respiratory agents: new viruses for old diseases? J Clin Virol, 2008,42(3):233-243. [4] Falade AG, Ayede AI. Epidemiology, aetiology and management of childhood acute community-acquired pneumonia in developing countries:a review. Afr J Med Med Sci, 2011,40(4):293-308. [5] Hall CB, Walsh EE. Respiratory syncytial virus. In textbook of pediatric infectious diseases. 6th ed.Philadelphia: Saunders,2009:2462-2487. [6] 宋斌,朱立军,黄其俊.浙江沿海地区急性下呼吸道感染患儿的病毒病原检测分析.放射免疫学杂志,2012,25(2):211-212. [7] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编委会.儿童社区获得性肺炎管理指南(试行)(上).中华儿科杂志,2007,45(2):83-90. [8] 洪巍,刁玉霞.新生儿感染性肺炎224例细菌学分析.中华全科医学,2011, 9 (6):915-916. [9] 罗圆,怀扬,余宏杰.发展中国家侵袭性肺炎链球菌病监测研究进展.中华流行病学杂志,2010,31(7):816-819. [10] 世界卫生组织对肺炎结合疫苗的意见书.中国计划免疫,2007,13(6):614-615. [11] 杨启文,徐英春,谢秀丽,等.全国10所医院院内与社区感染常见病原菌耐药性分析.中华医院感染学杂志,2009,19 (9):1133-1138. [12] 黄璐,季伟,丁云芳,等.儿童肺炎链球菌急性下呼吸道感染耐药监测. 临床儿科杂志,2010,28(6):538-541. [13] Tan TQ. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev, 2012,25(3):409-419. [14] 姚开虎,杨永弘.关注肺炎链球菌结合疫苗应用后的血清型替换现象.2008, 临床儿科杂志,26(7):555-558. [15] Gruber WC, Scott DA, Emini EA. Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM(197) conjugate vaccine. Ann N Y Acad Sci,2012,1263(1):15-26. [16] Sucher AJ,Chahine EB, Nelson M,et al. Prevnar 13, the new 13-valent pneumococcal conjugate vaccine.Ann Pharmacother,2011,45(12):1516-1124. [17] Cevey-Macherel M, Galetto-Lacour A, Gervaix A, et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr,2009, 168(12):1429-1436. [18] Principi N, Esposito S.Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax, 2011,66(9):815-822. [19] Westerink MA, Schroeder HW Jr, Nahm MH. Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. Aging Dis,2012, 3(1):51-67. [20] 李莉莉,郑凡,王健.肺炎链球菌蛋白疫苗候选蛋白研究进展.中国免疫学杂志,2012,28(6):573-576. [21] Kmietowicz Z. Pertussis cases rise 10-fold among older children and adults in England and Wales. BMJ,2012,345:e5008. [22] Nitsch-Osuch A, Kuchar E, Modrzejewska G, et al. Epidemiology of Pertussis in an Urban Region of Poland: Time for a Booster for Adolescents and Adults. Adv Exp Med Biol, 2012,755:203-212. [23] Centers for Disease Control and Prevention (CDC). Pertussis epidemic-washington, 2012. MMWR Morb Mortal Wkly Rep,2012,61:517-522. [24] 张颖,黄海涛,刘勇,等.天津市社区人群百日咳发病监测及传播特征研究. 中国疫苗和免疫,2011,17(3):209-211,257. [25] Hong JY. Update on pertussis and pertussis immunization. Korean J Pediatr,2010,53(5):629-633. [26] Bechini A, Tiscione E, Boccalini S,et al.Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations. Vaccine,2012,30(35):5179-5190. [27] Heininger U. Pertussis: what the pediatric infectious disease specialist should know. Pediatr Infect Dis J, 2012,31(1):78-79. [28] Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases: United States, 2009. MMWR Morb Mortal Wkly Rep,2011,58 (53):1-100. [29] Cherry JD, Seaton BL.Patterns of Bordetella parapertussis respiratory Illnesses: 2008—2010. Clin Infect Dis,2012,54(4):534-537. [30] World Health Organization. Global tuberculosis control: a short update to the 2009 report.WHO/HTM/TB/2009.426.Geneva:WHO,2009. [31] 李亮 端木宏谨.1979—2000 年四次全国儿童结核病流行病学抽样调查分析. 中华医学杂志,2004,84(20):1678-1680. [32] Wang PD.1998—2005年台湾儿童结核的流行病学趋势.于兰,译.国际结核病与肺部疾病杂志,2008,3(4):146-150. [33] Schaaf HS, Marais BJ, Hesseling AC, et al. Surveillance of antituberculosis drug resistance among children from the Wes-tern Cape Province of South Africa——an upward trend. Am J Public Health,2009,99(8):1486-1490. [34] Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr, 2012, 55(2): 42-47. [35] Bébéar C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol,2011,6(4):423-431. [36] 陈玲玲,成云改,陈志敏,等.肺炎支原体肺炎患儿混合感染的研究.中华儿科杂志,2012,50(3):211-215. [37] 中华医学会儿科学分会呼吸学组,中华医学会《中华儿科杂志》编辑委员会.哮喘危重状态的诊断和治疗.中华儿科杂志,2004,42(2):106-107. [38] Awasthi S, Yadav KK, Agarwal J. Chlamydia Pneumoniae Infection Associated with Uncontrolled Asthma: A Hospital Based Cross Sectional Study. Indian J Pediatr,2012 Jun 8. [Epub ahead of print]. [39] Bisgaard H,Hermansen MN,Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med, 2007,357(15):1487-1495. [40] Slinger R, Moldovan I, Barrowman N, et al.Successful nano-litre real-time PCR detection of respiratory pathogens in clinical specimens. Clin Microbiol Infect,2012,18(8):E286-288. [41] 蒋华芳,孔晓慧.呼吸道合胞病毒检测技术的研究进展.医学综述,2010,16(24):3772-3775; [42] Waites KB, Xiao L, Paralanov V, et al. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 william beaumont hospital symposium on molecular pathology. J Mol Diagn, 2012, 14(5):437-450. [43] Maiga M, Abaza A, Bishai WR. Current tuberculosis diagnostic tools & role of urease breath test. Indian J Med Res, 2012,135(5):731-736. |